Related Experiment Video
Updated: May 10, 2026

A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro
Published on: June 2, 2022
Coronary artery calcification and outcomes in diabetic patients with and without chronic kidney disease
D Russo1, L F P Morrone, M Imbriaco
1Department of Nephrology, University Federico II of Naples, Naples, Italy. domenicorusso51@hotmail.com
Insights
Diabetics with chronic kidney disease (CKD) show higher coronary artery calcification (CAC) prevalence and progression, leading to increased cardiovascular events (CVE). Aggressive screening and care are recommended for these high-risk patients.
Area of Science:
- Cardiovascular Medicine
- Nephrology
- Diabetology
Background:
- Coronary artery calcification (CAC) signifies severe atherosclerosis and predicts cardiovascular events (CVE) in chronic kidney disease (CKD) and end-stage renal disease (ESRD) patients.
- Atherosclerosis-driven CVE are a primary concern in CKD patients, particularly those with diabetes.
Purpose of the Study:
- To evaluate the prevalence, extent, and progression of CAC and CVE in CKD patients with diabetes.
- To identify risk factors associated with CAC and CVE in this population.
Main Methods:
- Retrospective study of 341 out- and in-patients with CKD stages 2-5.
- Coronary artery calcification (CAC) assessed via total calcium (TC) score using CT scans at baseline and study end.
Main Results:
- Diabetic CKD patients (n=60) exhibited higher CAC prevalence and TC scores compared to non-diabetic CKD patients (n=281).
- Higher CAC prevalence and TC scores were associated with age, diabetes mellitus, and pulse pressure.
- Diabetic CKD patients demonstrated a greater percentage of CAC progression and higher incidence of CVE.
Conclusions:
- Diabetic patients with CKD have a significantly higher prevalence, extent, and progression of CAC, alongside increased CVE.
- Findings suggest the need for intensified screening and management protocols for type 2 diabetics with concurrent CKD to mitigate cardiovascular risk.
Background/Aims:
Presence and progression of coronary artery calcification (CAC) indicate severe atherosclerosis and predict cardiovascular events (CVE) in dialysis (ESRD patients) and nondialysis patients (CKD patients). This study aimed at evaluating the prevalence and progression of CAC and CVE in CKD patients with diabetes in whom atherosclerosis of coronary arteries is the leading cause of CVE.
Methods:
This was a retrospective study conducted in both out- and in-patients with chronic kidney disease, stage 2-5. CAC were assessed by the total calcium (TC) score. CT scans were performed at the entry and at the end of the study.
Results:
Patients (n = 341) were divided into nondiabetic (n = 281) and diabetic patients (n = 60). CAC prevalence and TC score were higher in diabetics and associated with age, diabetes mellitus and pulse pressure. Diabetics with CKD presented a higher percentage of CAC progression and CVE.
Conclusion:
Prevalence, extent, progression of CAC and CVE are higher in diabetics with concomitant CKD. These findings may promote a more aggressive protocol of screening and care in type 2 diabetics with concomitant CKD.
Related Concept Videos
Diabetic Nephropathy
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease I: Introduction
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Chronic Kidney Disease III: Interprofessional Care
Coronary Artery Disease I: Introduction

